Lisa M. DeAngelis
Lisa M. DeAngelis[edit]
Early Life and Career[edit]
Lisa DeAngelis is a cancer researcher who specializes in the treatment of glioma.[1] patients and brain tumors as well as the neurologic complications of cancer[2]. She received her doctorate degree from Columbia University as well as complete her residency at Columbia University Medical Center[2]. She finished her fellowships in Neuro-Oncology and CUMB (Columbia University Medical Center)[3] and Memorial Sloan Kettering[4]. She is now the acting physician-in-chief for Memorial Sloan Kettering Cancer Center[5] while a search for Dr. Balsega’s[6] successor is conducted[7]. DeAngelis is the chairwoman of the department of oncology at Memorial Sloan Kettering[8]. She is a co-executive director for the Brain Tumor Center which supports research in brain tumors and promotes the use of the research into clinical trials[9]. She was elected to the Institute of Medicine, a branch of the National Academies that honors professional achievement in health services[10].
Research[edit]
She has investigated the role of small molecule inhibitors, anti-angiogenic therapy and molecular profiling in gliomas[1]. DeAngelis also began the study of primary CNS (central nervous system) lymphoma and its therapies[11]. She has also worked on brain imaging and is continually doing more research to create technology that can not only help detect abnormalities in the brain, but possibly help with treatment.[12]
Publications[edit]
Her most recent peer-reviewed article is titled The Trials of Neuro-Oncology Clinical Research and was released in 2018[13]. Her most notable articles include Brain Tumors (2001)[14], Radiation‐induced dementia in patients cured of brain metastases(1989)[15], and Neurological complications of cancer(2009)[16]
References[edit]
References[edit]
- ↑ 1.0 1.1 Schaff, Lauren R.; DeAngelis, Lisa M. (October 2017). "Novel Considerations in the Approach to Glioblastoma". Journal of Oncology Practice. 13 (10): 639–640. doi:10.1200/JOP.2017.027607. ISSN 1554-7477. PMC 5791835. PMID 29020536.
- ↑ 2.0 2.1 "Advisors :: Sapience Therapeutics, Inc". www.sapiencetherapeutics.com. Retrieved 2018-10-05.
- ↑ "Neuro-oncologist Lisa DeAngelis Elected to Institute of Medicine | Memorial Sloan Kettering Cancer Center". www.mskcc.org. Retrieved 2018-10-05.
- ↑ Gentile, Don (March 22, 1990). "Marathon man Lebow fighting brain cancer". The Daily News.
- ↑ "Memorial Sloan Kettering Cancer Center", Wikipedia, 2018-10-03, retrieved 2018-10-05
- ↑ "José Baselga", Wikipedia, 2018-09-16, retrieved 2018-10-05
- ↑ "Sloan Kettering's Cozy Deal With Start-Up Ignites a New Uproar". Retrieved 2018-10-05.
- ↑ Altman, Kolata, Lawrence, Gina (August 27, 2009). "Weighing Hope and Reality in Kennedy's Cancer Battle". The New York Times.
- ↑ "Dr. Lisa M. DeAngelis - NOB – Cognos Therapeutics". Cognos Therapeutics. Retrieved 2018-10-05.
- ↑ "Health and Medicine : Health and Medicine Division". www.nationalacademies.org. Retrieved 2018-10-05.
- ↑ "Central nervous system", Wikipedia, 2018-09-25, retrieved 2018-10-05
- ↑ Piana, Ronald (March 1, 2013). "The Challenges and Rewards of Neuro-oncology". The Asco Post.
- ↑ DeAngelis, Lisa M. “The Trials of Neuro-Oncology Clinical Research.” Neuro-Oncology, (20180606), 2018, doi:10.1093/neuonc/noy076.
- ↑ DeAngelis, Lisa M. "Brain tumors." New England Journal of Medicine 344, no. 2 (2001): 114-123.
- ↑ DeAngelis, Lisa M., Jean-Yves Delattre, and Jerome B. Posner. "Radiation‐induced dementia in patients cured of brain metastases." Neurology 39, no. 6 (1989): 789-789.
- ↑ DeAngelis, Lisa M., and Jerome B. Posner. Neurologic complications of cancer. Vol. 73. OUP USA, 2009.
This article "Lisa M. DeAngelis" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Lisa M. DeAngelis. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
